Numerous studies have reported the use of the GnRH peptide or its analogs as a targeting ligand to increase the potency of chemotherapeutic drugs, demonstrating the efficiency of the specific binding between GnRH peptide/analog-based carriers and the GnRH-R in cancer cells/tumors. Here, GNRH1 is linked to cancer.